Research on improving the compliance of liver cancer early screening follow-up in patients with chronic liver diseases through follow-up management based on digital information platform
10.3969/j.issn.1671-8283.2025.05.007
- VernacularTitle:基于数字化信息平台的随访管理提高慢性肝病患者肝癌早期筛查依从性研究
- Author:
Wei WANG
1
;
Yuxian KUANG
;
Yingfang YANG
;
Zhenjiao SU
;
Ningning FAN
;
Min TANG
;
Biyun ZHOU
;
Liqiao WU
Author Information
1. 珠海市人民医院.北京理工大学附属医院,暨南大学1珠海临床医学院护理部,广东 珠海,519000
- Publication Type:Journal Article
- Keywords:
digital information platform;
chronic liver disease;
liver cancer screening;
follow-up management;
revisit rate;
medication compliance
- From:
Modern Clinical Nursing
2025;24(5):49-55
- CountryChina
- Language:Chinese
-
Abstract:
Objective To explore the effect of follow-up management based on the digital information platform on the compliance of early screening and follow-up of liver cancer in patients with chronic liver diseases,and to provide a management method for clinical practice.Methods Convenience sampling was adopted to include 3,959 patients who had chronic liver diseases and visited the outpatient clinic of the Department of Infectious Liver Diseases in our hospital from January 2022 to December 2023.Before the application of the digital information platform for management,it was the medical staff of the Infectious Liver Disease Department who conducted telephone follow-ups and handwritten registrations for patients with chronic liver diseases within one week after their visits.After management,A liver cancer prediction model installed in the digital information platform of the hospital automatically collected data of the patients,including information about the diseases and results of examinations for intelligent risk stratification of liver cancer.The nurses who were in charge of the follow-up performed individualised follow-up reviews based on the levels of risk.Follow-up re-visit rate of the patients in very high-and high-risks were calculated.Scores of chronic disease self-efficacy and medication compliance were compared before and at 3 months after the follow-up management.Results A total of 3,860 patients completed the study.After the follow-up management,the total follow-up re-visit rate of the patients was 88.2%(1,818/2,062)and that of the high-risk patients was 95.3%(246/258)in 2022,while those in 2023 were 94.0%(1,691/1,798)and 98.3%(232/236),respectively.After 3 months of follow-up management,scores for medication compliance and chronic disease self-efficacy showed significant improvement in comparison with those before the implementation of follow-up management(P<0.001).Conclusion The follow-up management based on a digital information platform is suitable for screening of early liver cancer in the patients with chronic liver diseases,as it improves the re-visit rate of patients for follow-up,medication compliance and self-efficacy.
